1 / 4

Global Heparin Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

The global heparin market is estimated to grow at a CAGR of around 3% during the forecast period. The major factors contributing to the growth of the market include a significant rise in the number of venous thromboembolism and cardiovascular disorders such as coronary heart disease and heart attack. Heparin is an anticoagulant or a blood thinner used to prevent blood clots in the patients suffering from a heart attack, and strokes.

larebomrglobal
Download Presentation

Global Heparin Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Global Heparin Market:Industry Growth, Size, Share and Forecast 2019-2025 Request a Free Sample of our Global Heparin Market: https://www.omrglobal.com/request- sample/heparin-market -------------------------------------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040

  2. A significant prevalence of venous thromboembolism and CVD (cardiovascular disease) is the major factor in promoting the growth of the global heparin market. In 2018, the Centre for Disease Control and Prevention (CDC ) published a report in which it stated that more than 900,000 people only in the US are affected by deep vein thrombosis and pulmonary embolism every year. More than 18 million people die across the globe due to cardiovascular disorder this shows an immense opportunity for the heparin market to grow as heparin is the primary drug used as an anticoagulant used to prevent blood clotting. A full Report of Global Heparin Market is Available at: https://www.omrglobal.com/industry- reports/heparin-market Heart diseases such as CVD and stroke; among other heart diseases are the leading causes of mortalities across the globe. According to the CDC, every 40 seconds, an individual in the US has a heart attack. In addition, around 805,000 Americans have a heart attack every year. According to the WHO, around 17.9 million fatalities occur due to CVD in 2016, representing around 31% of global fatalities. Amongst these fatalities, around 7.4 million were due to CHD and approximately 6.7 million were due to stroke. By 2030, it has been projected that CVDs would be responsible for approximately 23.6 million mortalities across the globe. This growing prevalence of CVD induced the demand for the anticoagulant drug which will contribute to the heparin market. Request a Free Sample of our Global Heparin Market: https://www.omrglobal.com/request- sample/heparin-market Various players are receiving FDA approval for their new heparin drug formulas which will contribute to the global heparin market in the near future. For instance, in April 2019, B. Braun Medical Inc. announced its launch of Heparin Sodium Injection, USP. It is an FDA approved and first of its kind syringe with attached needle for subcutaneous and intravenous use. It is designed with an aim to provide their patients with a better treatment experience with reduced risk of errors and expanding its product portfolio in the US in the medical field. Global Heparin Market Segmentation By Product Unfractionated Heparin Ultra-Low Molecular Weight Heparin (ULMWH) Low molecular weight Heparin (LMWH) By Route of Administration Intravenous Subcutaneous

  3. By Application Atrial Fibrillation & Heart Attack Coronary Heart Disease Pulmonary Embolism (PE) Deep Vein Thrombosis (DVT) Others Global Heparin Market – Segment by Region North America United States Canada Europe Germany UK France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific Rest of the World Company Profiles B Barun Melsungen AG Baxter International Inc. Eisai Co. Ltd. F. Hoffman-La Roche Ltd. Fresenius Kabi AG

  4. GlaxoSmithKline plc Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Hikma Pharmaceuticals PLC Leo Pharma A/S Mylan N.V. Nanjing Jianyou Biochemical Pharmaceutical Co. Ltd. Novartis AG Opocrin S.P.A Pfizer Inc. Sanofi S.A. Syntex S.A. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/heparin-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related